Results 41 to 50 of about 23,635 (276)

Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial. [PDF]

, 2015
BackgroundToxic epidermal necrolysis (TEN) is a rare systemic allergic drug eruption with high patient mortality. Currently, no established treatments have been shown to be effective for TEN beyond supportive care.
Kim, Kyoungmi, Li, Chin Shang, Maverakis, Emanual, Patel, Falin B, Patel, Forum, Sharon, Victoria R, Wilken, Reason   +6 more
core   +4 more sources

Lower Extremity Salvage in the Setting of Bullous Pemphigoid Exacerbation: A Case Report

Plastic and Reconstructive Surgery, Global Open, 2021
Summary:. Bullous pemphigoid is an autoimmune blistering disease where patients suffer from painful bullae, often covering large portions of the skin and requiring management with immune-suppression.
Samara E. Pollock, MD, Shauna M. Rice, BS, Sarah D. Ferree, MD, Jonathan Friedstat, MD, MPH, Kyle Eberlin, MD, Arianne S Kourosh, MD MPH   +5 more
doaj   +1 more source

Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic non-inferiority randomised controlled trial [PDF]

, 2017
Background: Bullous pemphigoid (BP) is a blistering skin disorder with increased mortality. We tested whether a strategy of starting treatment with doxycycline conveys acceptable short-term blister control whilst conferring long-term safety advantages ...
A Anstey, A Carmichael, A Lloyd Lavery, A M Layton, A Omerod, Adam Ferguson, Adzura Azam, Alex Waters, Andrew Ilchyshyn, Andrew J Nunn, Andrew Wright, Anna Chapman, B Walker, Bastuji-Garin, Bratton, Brick, C Barnard, C Günthert, C Thomas, Chalmers, Chalmers, Chris Bower, Chris Lovell, D'Agostino, David Gawkrodger, Diane Whitham, E Bröcker, E Veysey, Emilia Duarte-Williamson, Enno Schmidt, F Craig, Feliciani, Fenella Wojnarowska, Fiona Antony, Fivenson, G Patel, G Wong, Goon, Gudula Kirtschig, H Bell, H Malhomme, H Santander, Hofmann, Hywel C Williams, Indre Verpetinske, Ingrid Salvary, J Adams, J English, J Ingram, J Ravenscroft, J Wee, James Mason, Jane Sterling, Joanne R Chalmers, Joly, Joly, Joly, K Davies, K Hussain, K Steinbrink, Karen Gibbon, Karen Harman, Kathy Taghipour, Kirtschig, Langan, Lever, Lloyd-Lavery, M G S Dunnill, M Sticherling, M Vatve, M Walsh, M Westmoreland, Margaret Childs, Marinella Nik, Meijer, Monk, Murrell, N Hepburn, N J Levell, N van Beek, Offen, P J Hampton, R Ellis, R Gläser, R Groves, R Hügel, R R Coelho, R Rallan, R Wachsmuth, Riond, Robert Charles-Holmes, Roujeau, S Blackford, S Wahie, Sam Gibbs, Savin, Schmidt, Schulze, Shernaz Walton, Sobocinski, Taghipour, Taghipour, Thomas Luger, Thomas R Godec, V Akhras, V Lewis, V Venning, Venning, Walter Bottomley   +108 more
core   +4 more sources

Clinical Relevance of Autoantibodies in Patients with Autoimmune Bullous Dermatosis

Clinical and Developmental Immunology, 2012
The authors present their experience related to the diagnosis, treatment, and followup of 431 patients with bullous pemphigoid, 14 patients with juvenile bullous pemphigoid, and 273 patients with pemphigus.
Lilla Mihályi, Mária Kiss, Attila Dobozy, Lajos Kemény, Sándor Husz   +4 more
doaj   +1 more source

Pemphigoid gestationis and intravenous immunoglobulin therapy

International Journal of Women's Dermatology, 2018
Pemphigoid gestationis, which is also known as herpes gestationis, is a rare, pregnancy-associated, autoimmune bullous disease. Treatment depends on the severity of the disease for each patient and the safety and use of these drugs during pregnancy and ...
Anes Yang, MD, BMed, MPH, Elizabeth Uhlenhake, MD, FAAD, Dedee F. Murrell, MA, BMBCh, FAAD, MD, FACD, FRCP   +2 more
doaj   +1 more source

Dupilumab Beyond the Airway: Decreased Morbidity in a Real‐World Analysis

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Post hoc analyses of clinical trials have characterized dupilumab's adverse effects, yet the real‐world impact in chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma is not well described. This study aims to characterize the risks of lymphoma, cardiovascular events, eosinophilia, joint pain, inflammatory arthritis, and ...
Emma J. Anisman, Spencer Short, Emma Tam, Benjamin F. Bitner, Abdulghafoor Alani, Marc Rosen, Mindy Rabinowitz, Damaris Pena Evertz, Elina Toskala, Gurston G. Nyquist   +9 more
wiley   +1 more source

A case of porphyria cutanea tarda in the setting of hepatitis C infection and tobacco usage [PDF]

, 2019
Porphyria cutanea tarda (PCT) is the most common type of porphyria, presenting in middle-aged patients with a photodistributed vesiculobullous eruption, milia, and scars.
Brinster, NK, Chen, L, Lederhandler, M, Meehan, SA, Neimann, A   +4 more
core  

The Rare Presentation of Deep Dermatophytosis‐Trichophyton in an Immunosuppressed Patient

JEADV Clinical Practice, EarlyView.
ABSTRACT Dermatophytes typically cause superficial skin infections characterized by an active border. However, they can present atypically invading deeper in immunocompromised patients. We present a case of a 72‐year‐old woman with bullous pemphigoid who had received oral prednisolone for 3 months and developed umbilicated papules.
Jidapa Triwatcharikorn, Nitina Yeesibsean, Jirapon Jesrichai, Chanat Kumtornrut   +3 more
wiley   +1 more source

Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis

PLoS ONE, 2022
Objective To systematically evaluate the prognostic factors for mortality in bullous pemphigoid. Methods PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, China Biology Medicine disc and Wanfang Database were searched to collect ...
Xianxia Chen, Yaqiang Zhang, Zhicheng Luo, Yujuan Wu, Taoxiang Niu, Jiayuan Zheng, Yuanyuan Xie   +6 more
doaj   +2 more sources

A case report of bullous pemphigoid following secukinumab therapy for a patient with psoriasis

Journal of Dermatological Treatment
Aim: Bullous pemphigoid induced by secukinumab in treatment of psoriasis is rare.Methods: We report a 49-year-old man with psoriasis who developed bullous pemphigoid during treatment with secukinumab.Results: Scattered tense vesicles with itching ...
Guanghan Wang, Xiaojing Hu, Shixin Han, Meijuan Zhou   +3 more
doaj   +1 more source